126 related articles for article (PubMed ID: 38423221)
1. Colorectal neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasm: Prognostic factors and PD-L1 expression.
Ho YH; Hsu CY; Yau Li AF; Liang WY
Hum Pathol; 2024 Mar; 145():80-85. PubMed ID: 38423221
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of clinicopathological characteristics, therapeutic strategy and prognosis of 501 patients with gastric neuroendocrine neoplasms attending a single center].
Zhang BL; Lu YX; Liang WQ; Gao YH; Xi HQ; Wang XX; Zhang KC; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):459-466. PubMed ID: 37217354
[No Abstract] [Full Text] [Related]
3. Clinicopathological features and prognostic factors associated with gastroenteropancreatic mixed neuroendocrine non-neuroendocrine neoplasms in Chinese patients.
Huang YC; Yang NN; Chen HC; Huang YL; Yan WT; Yang RX; Li N; Zhang S; Yang PP; Feng ZZ
World J Gastroenterol; 2021 Feb; 27(7):624-640. PubMed ID: 33642833
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characteristics of gastric neuroendocrine neoplasms: A comprehensive analysis.
Zi M; Ma Y; Chen J; Pang C; Li X; Yuan L; Liu Z; Yu P
Cancer Med; 2024 Feb; 13(4):e7011. PubMed ID: 38457192
[TBL] [Abstract][Full Text] [Related]
5. BRAF
Dizdar L; Werner TA; Drusenheimer JC; Möhlendick B; Raba K; Boeck I; Anlauf M; Schott M; Göring W; Esposito I; Stoecklein NH; Knoefel WT; Krieg A
Int J Cancer; 2019 Mar; 144(6):1379-1390. PubMed ID: 30144031
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of mismatch repair deficiency screening in patients with mixed neuroendocrine non-neuroendocrine neoplasms (MiNEN).
Lou L; Lv F; Wu X; Li Y; Zhang X
Eur J Surg Oncol; 2021 Feb; 47(2):323-330. PubMed ID: 32907775
[TBL] [Abstract][Full Text] [Related]
7. Long-term surgical outcomes of gastric neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasms.
Iwasaki K; Barroga E; Enomoto M; Tsurui K; Shimoda Y; Matsumoto M; Miyoshi K; Ota Y; Matsubayashi J; Nagakawa Y
World J Surg Oncol; 2022 May; 20(1):165. PubMed ID: 35610656
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine carcinoma and mixed neuroendocrine‒non-neuroendocrine neoplasm of the stomach: a clinicopathological and exome sequencing study.
Ishida S; Akita M; Fujikura K; Komatsu M; Sawada R; Matsumoto H; Saegusa J; Itoh T; Kakeji Y; Zen Y
Hum Pathol; 2021 Apr; 110():1-10. PubMed ID: 33359239
[TBL] [Abstract][Full Text] [Related]
9. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.
Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK
Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419
[TBL] [Abstract][Full Text] [Related]
10. Do neuroendocrine carcinomas and mixed neuroendocrine-non-neuroendocrine neoplasm of the gastrointestinal tract have the same prognosis? A
Shi H; Qi C; Meng L; Yao H; Jiang C; Fan M; Pang S; Zhang Q; Lin R
Ther Adv Endocrinol Metab; 2020; 11():2042018820938304. PubMed ID: 32670540
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic features and lymph node metastasis pattern of the cervical MiNEN.
Xu H; Zhao Z; Zhu Y
Endocrine; 2022 May; 76(2):474-483. PubMed ID: 35102503
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of mutational and clinicopathologic characteristics of poorly differentiated colorectal neuroendocrine carcinomas.
Lee SM; Sung CO
Sci Rep; 2021 Mar; 11(1):6203. PubMed ID: 33737597
[TBL] [Abstract][Full Text] [Related]
13. Impact of KRAS and BRAF mutations on treatment efficacy and survival in high-grade gastroenteropancreatic neuroendocrine neoplasms.
Elvebakken H; Hjortland GO; Garresori H; Andresen PA; Janssen EAM; Vintermyr OK; Lothe IMB; Sorbye H
J Neuroendocrinol; 2023 Apr; 35(4):e13256. PubMed ID: 37017614
[TBL] [Abstract][Full Text] [Related]
14. Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same Coin.
Busico A; Maisonneuve P; Prinzi N; Pusceddu S; Centonze G; Garzone G; Pellegrinelli A; Giacomelli L; Mangogna A; Paolino C; Belfiore A; Kankava K; Perrone F; Tamborini E; Pruneri G; Fazio N; Milione M
Neuroendocrinology; 2020; 110(7-8):616-629. PubMed ID: 31557757
[TBL] [Abstract][Full Text] [Related]
15. PD-L1 Expression in colorectal carcinoma and its correlation with clinicopathological parameters, microsatellite instability and BRAF mutation.
Srivastava P; Husain N; Shukla S; Chauhan S; Pandey A; Masood S
Indian J Pathol Microbiol; 2021; 64(3):490-496. PubMed ID: 34341259
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling of pancreatic neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasm.
Kinowaki Y; Fukumura Y; Kawade G; Sugita K; Kinowaki K; Akahoshi K; Kobayashi M; Ono H; Kudo A; Tanabe M; Akashi T; Ohashi K; Kurata M
Gene; 2024 Jan; 893():147916. PubMed ID: 37866661
[TBL] [Abstract][Full Text] [Related]
17. PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes.
Rosenbaum MW; Bledsoe JR; Morales-Oyarvide V; Huynh TG; Mino-Kenudson M
Mod Pathol; 2016 Sep; 29(9):1104-12. PubMed ID: 27198569
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features and lymph node and distant metastasis patterns in patients with gastroenteropancreatic mixed neuroendocrine-non-neuroendocrine neoplasm.
Zhang P; Li Z; Li J; Li J; Zhang X; Lu Z; Sun Y; Li Y; Zhou J; Wang X; Peng Z; Shen L; Lu M
Cancer Med; 2021 Jul; 10(14):4855-4863. PubMed ID: 34109756
[TBL] [Abstract][Full Text] [Related]
19. Acquired resistance to BRAF inhibitors is mediated by BRAF splicing variants in BRAF V600E mutation-positive colorectal neuroendocrine carcinoma.
Shimizu Y; Maruyama K; Suzuki M; Kawachi H; Low SK; Oh-Hara T; Takeuchi K; Fujita N; Nagayama S; Katayama R
Cancer Lett; 2022 Sep; 543():215799. PubMed ID: 35724767
[TBL] [Abstract][Full Text] [Related]
20. Colorectal neuroendocrine carcinomas and adenocarcinomas share oncogenic pathways. A clinico-pathologic study of 12 cases.
Karkouche R; Bachet JB; Sandrini J; Mitry E; Penna C; Côté JF; Blons H; Penault-Llorca F; Rougier P; Saint André JP; Emile JF
Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1430-7. PubMed ID: 23114745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
